Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-09-13

Clinical Trial Update: Clonidine to Treat Iatrogenic-induced Opioid Dependence in Infants [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for clonidine in treating iatrogenic opioid dependence in neonates with neonatal abstinence syndrome; study terminated with results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clonidine (clonidine)

Snippet

Sponsor: Johns Hopkins University | Conditions: Neonatal Abstinence Syndrome | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2017-09-13